Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications in metabolic studies. This synthetic peptide compound demonstrates significant potential in glycemic control research through its unique dual-receptor activation mechanism.
The compound works by simultaneously stimulating both GIP and GLP-1 receptors, making it particularly valuable for studying insulin secretion pathways and glucagon regulation in controlled research environments. Current studies focus on its potential applications in metabolic disorder research and related pharmaceutical development.
Important Note: This product is synthesized exclusively for laboratory research purposes. It is not intended for human consumption or clinical use. Proper handling procedures must be followed by qualified researchers only.
